Zanubrutinib, Lenalidomide and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma: A Multi-center Phase II trial in Chinese Cohort by Jiangsu Cooperative Lymphoma Group (JCLG)